ODI Pharma AB (“ODI Pharma” or the “Firm”), a producer and consultant of completed pharmaceutical hashish and cosmetics merchandise, now launches kandol., a CBD skincare product line. The merchandise will, as an preliminary step, be obtainable on-line at www.kandol.net to clients inside the EU beginning mid-September 2021.
On 14 January 2021, the Firm introduced its determination to implement a brand new enterprise space consisting of specialised, extremely CBD-infused skincare merchandise (“Venture Pores and skin”). After an intensive analysis of the market and its potential for sure product varieties, the Firm has carried out in depth analysis on discovering the most effective formulation for the merchandise and in the end outlined a product line which is now produced and launched to the market underneath the model “kandol.“. Moreover, ODI Pharma is presently increasing the distribution channels (on-line and stationary) for the product line and has up to now constructed strong relationships in lots of European international locations.
The product line initially consists of a CBD-infused facial cream, facial masks and physique balm. The merchandise include what the Firm describes because the Golden Commonplace of Cannabidiol (CBD) and are designed to the EU-approved definition of Cannabidiol as an antioxidant, antiseborrheic, pores and skin conditioner and pores and skin protector. The dermatological effectivity assessments had been run on the facial cream by an unbiased multinational firm specializing in beauty testing on 40 check topics following the EU rules. Take a look at outcomes have confirmed kandol. as one of the crucial efficient skincare merchandise and show that the Firm has discovered a disrupting method that exhibits excellent results. Amongst different issues, the product improves the looks of the pores and skin and in contrast with the identical kind of merchandise used previously, the examined product was assessed as higher than (57%) or comparable with (40%) the most effective merchandise the check topics had ever examined earlier than, which means 97% of check topics discovered ODI Pharma’s product higher or comparable. Examined results had been amongst others purifying pores, decreasing look of wrinkles, bettering pores and skin situation, giving wholesome look, pores and skin smoothening, nourishing, defending from drying and leaving the pores and skin moisturized bettering redness, decreasing indicators of fatigue and speed up the disappearance of blemishes.
“After intensive preparation, I am very excited to replace that we’re launching kandol. CBD infused luxurious skincare line. Preliminary unbiased testing confirms our perception of excellence of our merchandise. We’re assured that kandol. represents vital progress potential for ODI Pharma and with anticipated revenues beginning in mid-September 2021. We’re wanting ahead to the continued journey of bettering life high quality by the applying of cannabinoids – now additionally as skincare merchandise.” – says Derek Simmross, CEO.
For extra info on ODI Pharma, please contact:
Derek Simmross, CEO, ODI Pharma AB
ODI Pharma AB
ODI Pharma, based mostly on its European community, subsidiaries and associates, is a producer and consultant of completed pharmaceutical hashish and cosmetics merchandise with a concentrate on distribution to the medical hashish market in Europe via its subsidiary ODI Pharma Polska Sp. z o.o. ODI Pharma intends to supply a high-quality product at a aggressive value in comparison with rivals in Poland, thereby turning into the primary supplier of medical hashish in Poland. ODI Pharma additionally strives to be on the forefront of understanding the medical functions of the product in addition to introducing new, progressive merchandise to the European sufferers in want. The Firm will proceed to group up with probably the most educated and greatest renown companions within the business to attain its objectives.
(c) 2021 Cision. All rights reserved., supply Press Releases – English